Biocon Biologics
Suresh Revanna is a Senior Manager at Biocon Biologics, with experience in data governance QA and qualification software applications for 21 CFR compliance. Suresh has held senior roles at Novartis, Emcure Pharmaceuticals Limited, Micro Labs Ltd., and Sanford Pharmatech Pvt Ltd., specializing in analytical formulations development and method validation. Suresh has a strong educational background in chemistry and management, with degrees from the University of Mysore and Symbiosis Institute of Management Studies. Suresh also received training on integrated management systems from TÜV Rheinland-Schulen Gera.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics